# Folic Acid Supplementation in Calcific Aortic Valve Disease

> **NCT05861648** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 100 (estimated)

## Conditions studied

- Calcification of Aortic Valve
- Aortic Valve Stenosis

## Interventions

- **DRUG:** Folic Acid Oral Tablet
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05861648
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05861648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05861648, "Folic Acid Supplementation in Calcific Aortic Valve Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05861648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*